Surprising new randomized trial data showed no clinically relevant decrease in bone mineral density at various skeletal sites 12 months after kidney transplantation in patients receiving baseline calcitriol and calcium therapy as well as ibandronate or placebo. These data raise important questions regarding strategies to prevent bone loss after renal transplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Julian, B. A. et al. Rapid loss of vertebral mineral density after renal transplantation. N. Engl. J. Med. 325, 544–550 (1991).
Brandenburg, V. M., Westenfeld, R. & Ketteler, M. The fate of bone after renal transplantation. J. Nephrol. 17, 190–204 (2004).
Palmer, S. C., McGregor, D. O. & Strippoli, G. F. Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst. Rev. Issue 3. Art. No.: CD005015 http://dx.doi.org/10.1002/14651858.CD005015.pub3.
Kalantar-Zadeh, K., Molnar, M. Z., Kovesdy, C. P., Mucsi, I. & Bunnapradist, S. Management of mineral and bone disorder after kidney transplantation. Curr. Opin. Nephrol. Hypertens. 21, 389–403 (2012).
Smerud, K. T. et al. A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation. Am. J. Transplant. http://dx.doi.org/10.1111/j.1600-6143201204233.x.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD–MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int. Suppl. 113, S1–S130 (2009).
Coco, M. et al. Effect of risedronate on bone in renal transplant recipients. J. Am. Soc. Nephrol. 23, 1426–1437 (2012).
Grotz, W. et al. Effect of ibandronate on bone loss and renal function after kidney transplantation. J. Am. Soc. Nephrol. 12, 1530–1537 (2001).
De Sévaux, R. G., Hoitsma, A. J., Corstens, F. H. & Wetzels, J. F. Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study. J. Am. Soc. Nephrol. 13, 1608–1614 (2002).
Mainra, R. & Elder, G. J. Individualized therapy to prevent bone mineral density loss after kidney and kidney–pancreas transplantation. Clin. J. Am. Soc. Nephrol. 5, 117–124 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Brandenburg, V., Floege, J. An end to bone disease after renal transplantation?. Nat Rev Nephrol 9, 5–6 (2013). https://doi.org/10.1038/nrneph.2012.245
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2012.245
